Correlation Between FrontView REIT, and Telomir Pharmaceuticals,

Can any of the company-specific risk be diversified away by investing in both FrontView REIT, and Telomir Pharmaceuticals, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining FrontView REIT, and Telomir Pharmaceuticals, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between FrontView REIT, and Telomir Pharmaceuticals, Common, you can compare the effects of market volatilities on FrontView REIT, and Telomir Pharmaceuticals, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in FrontView REIT, with a short position of Telomir Pharmaceuticals,. Check out your portfolio center. Please also check ongoing floating volatility patterns of FrontView REIT, and Telomir Pharmaceuticals,.

Diversification Opportunities for FrontView REIT, and Telomir Pharmaceuticals,

0.22

Correlation Coefficient

FrontView REIT,  Telomir Pharmaceuticals,

Modest diversification

The 3 months correlation between FrontView and Telomir is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding FrontView REIT, and Telomir Pharmaceuticals, Commo in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telomir Pharmaceuticals, and FrontView REIT, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on FrontView REIT, are associated (or correlated) with Telomir Pharmaceuticals,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telomir Pharmaceuticals, has no effect on the direction of FrontView REIT, i.e., FrontView REIT, and Telomir Pharmaceuticals, go up and down completely randomly.

Pair Corralation between FrontView REIT, and Telomir Pharmaceuticals,

Considering the 90-day investment horizon FrontView REIT, is expected to generate 0.17 times more return on investment than Telomir Pharmaceuticals,. However, FrontView REIT, is 5.75 times less risky than Telomir Pharmaceuticals,. It trades about 0.02 of its potential returns per unit of risk. Telomir Pharmaceuticals, Common is currently generating about -0.03 per unit of risk. If you would invest  1,900  in FrontView REIT, on September 19, 2024 and sell it today you would earn a total of  12.00  from holding FrontView REIT, or generate 0.63% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	87.3%
Values	Daily Returns

FrontView REIT,  vs.  Telomir Pharmaceuticals, Commo

FrontView REIT,

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in FrontView REIT, are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable basic indicators, FrontView REIT, is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Telomir Pharmaceuticals,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Telomir Pharmaceuticals, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with FrontView REIT, and Telomir Pharmaceuticals,

The main advantage of trading using opposite FrontView REIT, and Telomir Pharmaceuticals, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if FrontView REIT, position performs unexpectedly, Telomir Pharmaceuticals, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telomir Pharmaceuticals, will offset losses from the drop in Telomir Pharmaceuticals,'s long position.

The idea behind FrontView REIT, and Telomir Pharmaceuticals, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.